Prothrombin Time (PT)
Introduction Tissue
thromboplastin is a lipoprotein found in many mammalian tissues. In the
presence of calcium ions, thromboplastin is capable of activating the
extrinsic pathway of coagulation. The Prothrombin Time (PT) Assay measures
the time to convert fibrinogen to fibrin by the action of thrombin. The PT
assay is sensitive to deficiencies in Factors II, V, VII and X. It can be
prolonged by hereditary coagulation disorders, liver disease, vitamin K
deficiency and oral anticoagulant therapy.

Indications for
Testing Individuals with a history of bleeding disorders or
liver disease and those taking oral anticoagulation therapy should be
tested with PT.

Detection Method Calcium
thromboplastin is used for the simultaneous determination of protrombin
time and fibrinogen in human plasma. PT is measured by the IL
TestTMPT-Fib.

Interpretation of Test
Results Normal expected values: 10.1 - 12.9 seconds.

Specimen Collection and Shipping
Requirements
- Collect one (1) blue top tube.
- Spin, separate, freeze and ship in prepaid FedEx mailers overnight,
next day morning.

Turn around Time Processing
of specimens begins immediately upon receipt at our facilities. Results
are routinely available within 7 to 10 days and are initially faxed, then
mailed to the requesting physician.

Cost
Included in our fees
are specimen collection and shipping materials, all courier and shipping
charges, telephone and written reports, and consultation with physicians.
Please call 1-877-737-7652 for pricing information.

Request Hard Copy

References Quick AJ.
Hemorrhagic diseases and thrombosis. In: Lea and Febiger. eds.
Philadelphia, 1966.
Kelsey PR, Stevenson KJ, Pollan L. The diagnosis of lupus
anticoagulants by the activated partial thromboplastin time. The central
role of phosphatidylserine. Thromb Haem 1984;52:172-75.
Brandt IT, Barna LK, Triplett DA. Laboratory identification of lupus
anticoagulants: results of the second international workshop for
identification of lupus anticoagulants. Thromb Haem 1995;74:1597-1603.

|